13 NOVEMBER 2021
|
|
ADULT HEMATOLOGY PROGRAM |
07.40-08.40
|
ORAL PRESENTATION SESSIONS 3
|
Demet Çekdemir, Güven Çetin, Vahap Okan
|
|
SESSION 16- ACUTE MYELOID LEUKEMIA
|
CHAIRS: Charles Schiffer - Erdal Kurtoğlu |
08.40-09.00
|
Essential Molecular Characterisation of AML Patients
|
Mehmet Yılmaz
|
09.00-09.20
|
How I Treat AML
|
Charles Schiffer
|
09.20-09.40
|
Targeted Therapy in AML Treatment
|
Giovanni Martinelli
|
09.40-10.00
|
Importance of Mınımal Residual Diesease Detection in
AML Treatment
|
Claudio Cerhcione
|
10.00-10.20
|
GENERAL DISCUSSION Chair: Düzgün Özatlı |
10.20-10.40
| COFFEE BREAK
|
|
Session 17 : Ph-NEGATIVE AND POSITIVE MPNs
|
CHAIRS: Tariq Mughal - Ayşe Tülin Tuğlular |
10.40-11.00
|
How I Treat Policytemia Vera
|
Francesco Passamonti
|
11.00-11.20
|
How I Treat Myelofibrosis
|
Tariq Mughal
|
11.20-11.40
|
When Standard TKIs Do Not Suffice
|
Pia Ranani
|
11.40-12.00
|
How I Treat Essential Thrombocythemia
|
Güray Saydam
|
12.00-12.20
|
GENERAL DISCUSSION Chair: Ömür Gökmen Sevindik |
|
12.20-13.20
|
LUNCH BREAK
|
13.20-14.00
|
BREAK
|
|
Session 18: MDS
|
CHAIRS: Rajko Kusec -
Mustafa Nuri Yenerel |
14.00-14.20
|
MDS Diagnosis - Often Easy - Occasionally Challenging
|
Moshe Mittelman
|
14.20-14.40
|
How I Treat MDS
|
Guillermo Garcia Manero
|
14.40-15:00
|
New Drugs for MDS
|
Elias Jabbour
|
15.00-15.20
|
Luspatercept in MDS
|
Mustafa Çetiner
|
15.20-15.40
|
GENERAL DISCUSSION Chair: Ant Uzay |
|
15.40-16.00
|
COFFEE BREAK
|
|
Session 19: NEW
BIOLOGICAL INSIGHTS INTO THE HEMATOLOGICAL DISEASES
|
CHAIRS: Vera Donnenberg - Nilgün Sayınalp |
16.00-16.15
|
Evolution of the Pleural Secretome Associated with
Pleural Metastasis.
|
Albert Donnenberg
|
16.15-16.30
|
Intrapleural Therapy to Drive Systemic Anti-Tumor
Immunity
|
Vera Donnenberg
|
16.30-16.45
|
The Promising Role of the HDHODH Inhibitors in the
Therapy of Acute and Chronic Myeloid Leukemias
|
Mohammad Houshmand
|
16.45-17.00
|
Congenital Erythrocyte Defects of the Paediatric Age
|
Achilles Iolascon
|
17.00-17.15
|
Invasive Fungal Infections in Heamatological Patients in COVID-19 Pandemic
|
Ömrüm Uzun
|
17.15-17.30
|
GENERAL DISCUSSION Chair: Pervin Topcuoğlu |
|
17.30
|
CLOSING
|
| |
|